vasoactive intestinal peptide

DRUG3 trials

Sponsors

Stony Brook University, Danish Headache Center, Glostrup University Hospital, Copenhagen

Conditions

HeadacheMigraineMigraine Without AuraRespiratory Distress SyndromeRespiratory Distress Syndrome, AdultSepsisUltrasonography, Doppler, TranscranialVasoactive Intestinal Peptide

Phase 1

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

CompletedNCT00004494

Stony Brook UniversityRespiratory Distress Syndrome, Respiratory Distress Syndrome, Adult, Sepsis

Start: 1998-09-30Target: 18Updated: 2022-05-04

Unknown Phase

Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

CompletedNCT00272896

Danish Headache CenterHeadache, Migraine, Ultrasonography, Doppler, Transcranial +1

Start: 2004-10-31End: 2005-09-30Target: 12Updated: 2006-01-09

Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance

CompletedNCT01471990

Glostrup University Hospital, CopenhagenMigraine Without Aura

Start: 2011-05-31End: 2012-06-30Updated: 2012-08-29